3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Leukemia, Myeloid, Chronic-Phase
4
Philadelphia Chromosome
3
Leukemia
3
Breast Neoplasms
3
Bronchiolitis Obliterans Syndrome
2
Translocation, Genetic
1
Pathologic Processes
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Leukemia, Myeloid
1
Hematologic Diseases
1
Glioblastoma
1
Bone Marrow Diseases
1
Blast Crisis
1
Advanced Breast Cancer (Parts 1 and 2)
1
Interventions
Taxes
2
Sunitinib
2
Paclitaxel
2
N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide
2
Carboplatin
2
vorolanib
1
selinexor
1
saracatinib
1
pembrolizumab
1
epacadostat
1
belinostat
1
amrubicin
1
Thymectomy
1
Robotic Surgical Procedures
1
Ramucirumab
1
Prednisone
1
Prednisolone
1
Pemetrexed
1
Nivolumab
1
NVP-BKM120
1
MK 2206
1
Lapatinib
1
Fentanyl
1
Erlotinib Hydrochloride
1
Doxepin
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thymoma
×
bosutinib
×
Clear all
No trials found.